AI Medical Scribe for Addiction Medicine: Important Compliance Considerations First

Addiction medicine has unique documentation requirements and stricter privacy protections than most specialties. Here's what physicians need to know before using an AI scribe in SUD treatment settings.

42 CFR Part 2: What It Means for AI Scribes

Unlike standard HIPAA-covered information, substance use disorder records under 42 CFR Part 2 have highly restricted redisclosure rules — they cannot be shared without patient consent even for treatment purposes in many circumstances. Any system that captures, stores, or processes SUD encounter content needs to be evaluated against Part 2 requirements, not just HIPAA.

The AI scribe's entire data chain — recording, transcription, processing, storage — needs to be reviewed for 42 CFR Part 2 compliance. This is a more specialized compliance evaluation than standard HIPAA BAA review.

Addiction Medicine Documentation Needs

MOUD visits — buprenorphine inductions, maintenance checks, naltrexone management — involve detailed documentation of substance use history, treatment response, urine drug screen interpretation, prescription monitoring review, and medication adjustments. The visits are information-dense and documentation is critical for controlled substance prescribing compliance.

Independent addiction medicine physicians — office-based MOUD prescribers, addiction psychiatrists — carry significant documentation burden per visit. An AI scribe that handles this accurately, combined with verified 42 CFR Part 2 compliance, would significantly reduce after-hours charting.

What to Verify Before Using Any AI Scribe in Addiction Medicine

FAQ